000 | 01800 a2200577 4500 | ||
---|---|---|---|
005 | 20250513064359.0 | ||
264 | 0 | _c19940629 | |
008 | 199406s 0 0 eng d | ||
022 | _a0278-0232 | ||
024 | 7 |
_a10.1002/hon.2900120104 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aParker, D | |
245 | 0 | 0 |
_aPrognosis in low grade non-Hodgkin's lymphoma: relevance of the number of sites involved, absolute lymphocyte count and serum immunoglobulin level. _h[electronic resource] |
260 |
_bHematological oncology _c |
||
300 |
_a15-27 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 | _aAdolescent |
650 | 0 | 4 | _aAdult |
650 | 0 | 4 | _aAged |
650 | 0 | 4 | _aAged, 80 and over |
650 | 0 | 4 |
_aBone Marrow _xpathology |
650 | 0 | 4 | _aCell Count |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aImmunoglobulin A _xblood |
650 | 0 | 4 |
_aImmunoglobulin G _xblood |
650 | 0 | 4 |
_aImmunoglobulin M _xblood |
650 | 0 | 4 |
_aImmunoglobulins _xblood |
650 | 0 | 4 |
_aLiver Neoplasms _xblood |
650 | 0 | 4 |
_aLymphocytes _xpathology |
650 | 0 | 4 |
_aLymphoma, Non-Hodgkin _xblood |
650 | 0 | 4 | _aMale |
650 | 0 | 4 | _aMiddle Aged |
650 | 0 | 4 | _aMultivariate Analysis |
650 | 0 | 4 | _aNeoplasm Staging |
650 | 0 | 4 | _aPrognosis |
650 | 0 | 4 |
_aSerum Albumin _xanalysis |
650 | 0 | 4 |
_aSplenic Neoplasms _xblood |
650 | 0 | 4 | _aSurvival Analysis |
700 | 1 | _aAlison, D L | |
700 | 1 | _aBarnard, D L | |
700 | 1 | _aChild, J A | |
700 | 1 | _aDovey, G | |
700 | 1 | _aFarish, J | |
700 | 1 | _aNorfolk, D R | |
700 | 1 | _aO'Brien, C J | |
700 | 1 | _aParapia, L A | |
700 | 1 | _aSharp, J | |
773 | 0 |
_tHematological oncology _gvol. 12 _gno. 1 _gp. 15-27 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1002/hon.2900120104 _zAvailable from publisher's website |
999 |
_c8194164 _d8194164 |